Discontinued — last reported Q4 '25
Apollo Global Management Interest Paid decreased by 13.2% to $190.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 2.1%, from $194.00M to $190.00M. Over 4 years (FY 2021 to FY 2025), Interest Paid shows an upward trend with a 15.6% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase in interest paid relative to debt levels may signal rising borrowing costs or higher leverage, while a decrease may indicate debt reduction or refinancing at lower rates.
The total cash outflow for interest payments on debt obligations, typically disclosed as a supplemental item in the cash...
Essential for comparing the cost of capital and debt burden across peers in the pharmaceutical industry.
cf_interest_paid| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $105.00M | $217.00M | $139.00M | $203.00M | $111.00M | $118.00M | $134.00M | $169.00M | $176.00M | $188.00M | $187.00M | $167.00M | $180.00M | $264.00M | $194.00M | $321.00M | $264.00M | $219.00M | $190.00M |
| QoQ Change | — | +106.7% | -35.9% | +46.0% | -45.3% | +6.3% | +13.6% | +26.1% | +4.1% | +6.8% | -0.5% | -10.7% | +7.8% | +46.7% | -26.5% | +65.5% | -17.8% | -17.0% | -13.2% |
| YoY Change | — | — | — | — | +5.7% | -45.6% | -3.6% | -16.7% | +58.6% | +59.3% | +39.6% | -1.2% | +2.3% | +40.4% | +3.7% | +92.2% | +46.7% | -17.0% | -2.1% |